These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7572068)

  • 21. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.
    London ED; Simon SL; Berman SM; Mandelkern MA; Lichtman AM; Bramen J; Shinn AK; Miotto K; Learn J; Dong Y; Matochik JA; Kurian V; Newton T; Woods R; Rawson R; Ling W
    Arch Gen Psychiatry; 2004 Jan; 61(1):73-84. PubMed ID: 14706946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug abuse among alcoholic women.
    Schuckit MA; Morrissey ER
    Am J Psychiatry; 1979 Apr; 136(4B):607-11. PubMed ID: 426153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative magnetic resonance tomography and the severity of deficits in dementia of the Alzheimer type].
    Pantel J; Schröder J; Schmitt R; Schad LR; Knopp MV; Geissler M; Uhde WH; Blüml S; Friedlinger M; Klemenz M; Essig M; Sauer H
    Nervenarzt; 1996 Jan; 67(1):46-52. PubMed ID: 8676988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased white matter hyperintensities in male methamphetamine abusers.
    Bae SC; Lyoo IK; Sung YH; Yoo J; Chung A; Yoon SJ; Kim DJ; Hwang J; Kim SJ; Renshaw PF
    Drug Alcohol Depend; 2006 Jan; 81(1):83-8. PubMed ID: 16005161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personality subtypes, coping styles, symptom correlates, and substances of choice among a cohort of substance abusers.
    Quirk SW; McCormick RA
    Assessment; 1998 Jun; 5(2):157-69. PubMed ID: 9626391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition and treatment of substance abuse in the elderly.
    Thibault JM; Maly RC
    Prim Care; 1993 Mar; 20(1):155-65. PubMed ID: 8464937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deformation-based brain morphometry to track the course of alcoholism: differences between intra-subject and inter-subject analysis.
    Rohlfing T; Sullivan EV; Pfefferbaum A
    Psychiatry Res; 2006 Mar; 146(2):157-70. PubMed ID: 16500088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of abstinent substance abusers who first sought treatment in adolescence.
    Marshall MJ; Marshall S; Heer MJ
    J Drug Educ; 1994; 24(2):151-62. PubMed ID: 7931925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroimaging in substance abuse disorders].
    de Mendelssohn A; Kasper S; Tauscher J
    Nervenarzt; 2004 Jul; 75(7):651-62. PubMed ID: 15300321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High school polydrug users and abusers.
    Wright LS
    Adolescence; 1985; 20(80):853-61. PubMed ID: 4083142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in the effects of alcohol on brain structure.
    Pfefferbaum A; Rosenbloom M; Deshmukh A; Sullivan E
    Am J Psychiatry; 2001 Feb; 158(2):188-97. PubMed ID: 11156800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging based correlation analysis between calcarine sulcus development and isolated fetal ventriculomegaly.
    Li H; Liang H; Wu H
    Congenit Anom (Kyoto); 2017 Mar; 57(2):52-56. PubMed ID: 27783870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personality study of alcohol, heroin, and polydrug abusers in an Arabian Gulf population.
    Amir T
    Psychol Rep; 1994 Apr; 74(2):515-20. PubMed ID: 8197289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain volume in autism.
    Hardan AY; Minshew NJ; Mallikarjuhn M; Keshavan MS
    J Child Neurol; 2001 Jun; 16(6):421-4. PubMed ID: 11417608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Referrals for psychiatric examination of driving ability - a comparison of illicit drugs and alcohol].
    Haberfellner EM
    Neuropsychiatr; 2008; 22(2):137-42. PubMed ID: 18606117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of patients with substance abuse diagnoses on a general psychiatry unit in a VA Medical Center.
    Lambert MT; Griffith JM; Hendrickse W
    Psychiatr Serv; 1996 Oct; 47(10):1104-7. PubMed ID: 8890339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.
    Kozora E; West SG; Kotzin BL; Julian L; Porter S; Bigler E
    Arthritis Rheum; 1998 Jan; 41(1):41-7. PubMed ID: 9433868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional magnetic resonance and spectroscopy in drug and substance abuse.
    Magalhaes AC
    Top Magn Reson Imaging; 2005 Jun; 16(3):247-51. PubMed ID: 16340649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volumetric cerebral characteristics of children exposed to opiates and other substances in utero.
    Walhovd KB; Moe V; Slinning K; Due-Tønnessen P; Bjørnerud A; Dale AM; van der Kouwe A; Quinn BT; Kosofsky B; Greve D; Fischl B
    Neuroimage; 2007 Jul; 36(4):1331-44. PubMed ID: 17513131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.